Literature DB >> 10543255

Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.

Y Imai1, Y Shiratori, N Kato, T Inoue, M Omata.   

Abstract

Genetic instability is a key mechanism of tumorigenesis, and the instability exists at two distinct levels, the nucleotide and the chromosome levels. Disruption of the mitotic spindle checkpoint is one of the underlying mechanisms leading to aneuploidy and alterations of hsMAD2 and hBUB1, assumed to take part in the spindle checkpoint in human cells, have been found to be associated with chromosomal instability in some tumor cell lines. Therefore, we investigated the mutational status of the hsMAD2 and hBUB1 genes in 32 sporadic digestive tract cancers by reverse transcription-polymerase chain reaction-single strand conformation polymorphism analysis. The entire coding sequence of the hsMAD2 gene, and conserved regions (codons 21-152 and codons 732-1043) presumed to be functionally important in the hBUB1 gene were analyzed. Mutation of the hsMAD2 gene was not observed at all and missense mutation of the hBUB1 gene was noted in one rectal cancer case. Sequencing analysis revealed an AGT-to-GGT missense mutation, substituting glycine for serine, at codon 950, which is conserved between budding yeast and human. These results indicate that mutations of the hsMAD2 and hBUB1 genes are very rare and presumably play a very restricted role in tumor development of sporadic cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543255      PMCID: PMC5926140          DOI: 10.1111/j.1349-7006.1999.tb00824.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  13 in total

1.  S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function.

Authors:  M A Hoyt; L Totis; B T Roberts
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

2.  Feedback control of mitosis in budding yeast.

Authors:  R Li; A W Murray
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

3.  A checkpoint on the road to cancer.

Authors:  T L Orr-Weaver; R A Weinberg
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

4.  Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage.

Authors:  S S Taylor; F McKeon
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Characterization of MAD2B and other mitotic spindle checkpoint genes.

Authors:  D P Cahill; L T da Costa; E B Carson-Walter; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Genomics       Date:  1999-06-01       Impact factor: 5.736

6.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

7.  The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase.

Authors:  B T Roberts; K A Farr; M A Hoyt
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

9.  Identification of a human mitotic checkpoint gene: hsMAD2.

Authors:  Y Li; R Benezra
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

Review 10.  Genetic instabilities in human cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

View more
  21 in total

1.  Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer.

Authors:  Michel V Hadjihannas; Martina Brückner; Boris Jerchow; Walter Birchmeier; Wolfgang Dietmaier; Jürgen Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

Review 2.  Mitotic checkpoint defects: en route to cancer and drug resistance.

Authors:  Sinjini Sarkar; Pranab Kumar Sahoo; Sutapa Mahata; Ranita Pal; Dipanwita Ghosh; Tanuma Mistry; Sushmita Ghosh; Tanmoy Bera; Vilas D Nasare
Journal:  Chromosome Res       Date:  2021-01-06       Impact factor: 5.239

3.  Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin.

Authors:  Li Wang; Fang Yin; Yulei Du; Bei Chen; Shuhui Liang; Yongguo Zhang; Wenqi Du; Kaichun Wu; Jie Ding; Daiming Fan
Journal:  Tumour Biol       Date:  2010-05-04

Review 4.  DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors:  S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal:  Curr Cancer Drug Targets       Date:  2012-05       Impact factor: 3.428

5.  Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.

Authors:  Naoyuki Homma; Gen Tamura; Teiichiro Honda; Zhe Jin; Kiyonari Ohmura; Sumio Kawata; Teiichi Motoyama
Journal:  Virchows Arch       Date:  2004-12-10       Impact factor: 4.064

6.  Aneuploid colon cancer cells have a robust spindle checkpoint.

Authors:  A Tighe; V L Johnson; M Albertella; S S Taylor
Journal:  EMBO Rep       Date:  2001-07-03       Impact factor: 8.807

7.  Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer.

Authors:  Chew-Wun Wu; Chin-Wen Chi; Tze-Sing Huang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance.

Authors:  Anna V Roschke; Oleg K Glebov; Samir Lababidi; Kristen S Gehlhaus; John N Weinstein; Ilan R Kirsch
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.

Authors:  Zheng Fu; Kevin Regan; Lizhi Zhang; Michael H Muders; Stephen N Thibodeau; Amy French; Yanhong Wu; Scott H Kaufmann; Wilma L Lingle; Junjie Chen; Donald J Tindall
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

10.  BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.

Authors:  Y-K Lee; E Choi; M A Kim; P-G Park; N-H Park; H Lee
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.